Healthcare -
Biotechnology - NYSE - US
$ 1.83
2.23 %
$ 35.7 M
Market Cap
-0.43
P/E
Price Target
Average
1302.55%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
36.04%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Annovis Bio, Inc.
Wall Street analysts predict an average 1-year price target for ANVS of $25.7 , with forecasts ranging from
a
low of
$21 to a high of $30 .
ANVS Lowest Price Target
Wall Street Target
21 USD
1047.54%
ANVS Average Price Target
Wall Street Target
25.7 USD
1302.55%
ANVS Highest Price Target
Wall Street Target
30 USD
1539.34%
REVENUE FORECAST
Revenue Forecast Chart ANVS
EBIT FORECAST
EBIT Forecast Chart ANVS
NET INCOME FORECAST
Net Income Chart ANVS